Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
One in 4 Medicare beneficiaries who are overweight or obese might be eligible for coverage of Wegovy now that it’s approved to reduce heart attack and stroke risk, according to a KFF analysis out today.
- Simplified Text
-
One in 4 Medicare beneficiaries overweight or obese might be eligible for Wegovy coverage
- Confidence Score
- 0.900
- Claim Maker
- KFF
- Context Type
- News Article
- Context Details
-
{ "drug": "Wegovy", "condition": "overweight or obese", "beneficiary": "Medicare beneficiaries", "organization": "KFF" } - UUID
- 9fdb0111-943d-4194-ad20-1788e0293f56
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:27 PM (22 hours ago)
- Last Updated
- September 11, 2025 at 10:27 PM (22 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
51
claims
🔥
22 hours ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical industry lobbying spending surged in Q1 2024. Increased spending focuses on PBM reform and other congressional issues. This follows recent government funding bill negotiations.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.